Digital technology has made important inroads to advance the self-management and treatment of cystic fibrosis (CF) symptoms. To date, no integrative, comprehensive, systematic review of digital technology and CF has included the application of digital technology for mental health. The purpose of the current study was to complete an up-to-date systematic review of digital technology interventions for CF across symptom monitoring, treatment adherence, airway clearance, nutrition, exercise, and mental health.
Methods:
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles reporting a quantitative study examining technology-based interventions for CF were included. Studies were excluded if they did not meet this criterion or if they were not written in English. PsycINFO, MEDLINE, EMBASE, and CINAHL databases were searched. Search terms included technology, CF, symptom monitoring, treatment adherence, quality of life, nutrition, exercise, and mental health.
Results:
Thirty-four studies were included in the review. Results demonstrated variable types of digital technologies, most predominantly applied to exercise. Inconsistencies were observed in terms of the effectiveness or efficacy of digital technology to address study outcomes across many application areas. Most consistent findings were found for the efficacy of digital technology applications for symptom monitoring (ie, improving early detection or prediction of pulmonary exacerbation), treatment adherence (ie, improvements in medication adherence, and nebulizer use), and mental health (ie, reductions in depression and anxiety).
Conclusions:
Digital technology applications offer the potential for improved CF care; however, many of the existing studies show limited evidence for their effectiveness. Well-designed, methodologically robust studies are required to fully understand the utility of digital technology in CF care.
AntoniouS and ElstonC. Cystic fibrosis. Medicine (Baltimore)2016; 44: 321–325; doi: 10.1016/j.mpmed.2016.02.016
2.
SawickiGS and TiddensH. Managing treatment complexity in cystic fibrosis: challenges and opportunities. Pediatr Pulmonol2012; 47: 523–533; doi: 10.1002/ppul.22546
3.
VolkovaN, MoyK, EvansJ, et al.Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries. J Cyst Fibros2020; 19: 68–79; doi: 10.1016/j.jcf.2019.05.015
4.
StephensonAL, SykesJ, StanojevicS, et al.Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study. Ann Intern Med2017; 166: 537–546; doi: 10.7326/M16-0858
Cystic Fibrosis Canada. The Canadian Cystic Fibrosis Registry 2023 Annual Data Report. CFC, 2025.
7.
MolinskiSV, ShahaniVM, SubramanianAS, et al.Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site. Proteins2018; 86: 833–843; doi: 10.1002/prot.25496
8.
StoltzDA, MeyerholzDK and WelshMJ. Origins of cystic fibrosis lung disease. N Engl J Med2015; 372: 351–362; doi: 10.1056/NEJMra1300109
9.
DaveK, DobraR, ScottS, et al.Entering the era of highly effective modulator therapies. Pediatr Pulmonol2021; 56(Suppl 1): S79–S89; doi: 10.1002/ppul.24968
10.
Balfour-LynnIM and KingJA. CFTR modulator therapies - Effect on life expectancy in people with cystic fibrosis. Paediatr Respir Rev2022; 42: 3–8; doi: 10.1016/j.prrv.2020.05.002
11.
McBennettKA, DavisPB and KonstanMW. Increasing life expectancy in cystic fibrosis: advances and challenges. Pediatr Pulmonol2022; 57(Suppl 1): S5–S12; doi: 10.1002/ppul.25733
12.
SawickiGS, RenCL, KonstanMW, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. et al.Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. J Cyst Fibros2013; 12: 461–467; doi: 10.1016/j.jcf.2012.12.009
13.
DaviesG, RowbothamNJ, SmithS, et al.Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials. J Cyst Fibros2020; 19: 499–502; doi: 10.1016/j.jcf.2019.10.025
14.
SawickiGS, SellersDE and RobinsonWM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros2009; 8: 91–96; doi: 10.1016/j.jcf.2008.09.007
15.
HabibA-RR, ManjiJ, WilcoxPG, et al.A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Ann Am Thorac Soc2015; 12: 420–428; doi: 10.1513/AnnalsATS.201408-393OC
16.
CalthorpeRJ, SmithS, GathercoleK, et al.Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review. Thorax2020; 75: 72–77; doi: 10.1136/thoraxjnl-2019-213233
17.
SmithAC, ThomasE, SnoswellCL, et al.Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare2020; 26: 309–313; doi: 10.1177/1357633X20916567
18.
QuittnerAL, GoldbeckL, AbbottJ, et al.Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax2014; 69: 1090–1097; doi: 10.1136/thoraxjnl-2014-205983
19.
YohannesAM, WillgossTG, FatoyeFA, et al.Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care2012; 57: 550–556; doi: 10.4187/respcare.01328
20.
PloesslC, PettitRS and DonaldsonJ. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother2014; 48: 488–493; doi: 10.1177/1060028013514846
21.
SnellC, FernandesS, BujoreanuIS, et al.Depression, illness severity, and healthcare utilization in cystic fibrosis. Pediatr Pulmonol2014; 49: 1177–1181; doi: 10.1002/ppul.22990
22.
SmithBA, ModiAC, QuittnerAL, et al.Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol2010; 45: 756–763; doi: 10.1002/ppul.21238
23.
RiekertKA, BartlettSJ, BoyleMP, et al.The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest2007; 132: 231–237; doi: 10.1378/chest.06-2474
24.
SilvaAM, DescalçoA, SalgueiroM, et al.Respiratory sleep disturbance in children and adolescents with cystic fibrosis. Rev Port Pneumol (2006)2016; 22: 202–208; doi: 10.1016/j.rppnen.2016.02.007
25.
AnderssonG, TitovN, DearBF, et al.Internet-delivered psychological treatments: from innovation to implementation. World Psychiatry2019; 18: 20–28; doi: 10.1002/wps.20610
26.
StoumposAI, KitsiosF and TaliasMA. Digital transformation in healthcare: technology acceptance and its applications. Int J Environ Res Public Health2023; 20: 3407; doi: 10.3390/ijerph20043407
27.
MoherD, LiberatiA, TetzlaffJ, PRISMA Group. et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 6: e1000097; doi: 10.1371/journal.pmed.1000097
28.
WrightJG, SwiontkowskiMF and HeckmanJD. Introducing levels of evidence to the journal. J Bone Joint Surg Am2003; 85: 1–3; doi: 10.2106/00004623-200301000-00001
29.
WoodJ, JenkinsS, PutrinoD, et al.A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: results of a randomised controlled trial. J Cyst Fibros2020; 19: 271–276; doi: 10.1016/j.jcf.2019.09.002
30.
CarnovaleV, IacotucciP, QiaoD, et al.Clinical outcomes of digital health in adults with cystic fibrosis. Respir Med2022; 202: 106970; doi: 10.1016/j.rmed.2022.106970
31.
van HorckM, WinkensB, WesselingG, et al.Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function. Sci Rep2017; 7: 12350. [Erratum in Sci Rep. 2018 Dec 13;8(1):17946. doi: 10.1038/s41598-018-36407-y.]; doi: 10.1038/s41598-017-10945-3
32.
CummingsE, HauserJ, Cameron-TuckerH, et al.Enhancing self-efficacy for self-management in people with cystic fibrosis. Stud Health Technol Inform2011; 169: 33–37; doi: 21893709
33.
LechtzinN, Mayer-HamblettN, WestNE, eICE Study Team. et al.Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results. Am J Respir Crit Care Med2017; 196: 1144–1151; doi: 10.1164/rccm.201610-2172OC
34.
RudolfI, PieperK, NolteH, et al.Assessment of a mobile app by adolescents and young adults with cystic fibrosis: pilot evaluation. JMIR Mhealth Uhealth2019; 7: e12442; doi: 10.2196/12442
35.
GurM, NirV, TeleshovA, et al.The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: a pilot study. J Telemed Telecare2017; 23: 489–493; doi: 10.1177/1357633X16649532
36.
ModiAC and QuittnerAL. Utilizing computerized phone diary procedures to assess health behaviors in family and social contexts. Child Health Care2006; 35: 29–45; doi: 10.1207/s15326888chc3501_4
37.
McNamaraPS, McCormackP, McDonaldAJ, et al.Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cyst Fibros2009; 8: 258–263; doi: 10.1016/j.jcf.2009.04.006
38.
WildmanMJ, O’CathainA, MaguireC, CFHealthHub Study Team. et al.Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial. Thorax2022; 77: 461–469; doi: 10.1136/thoraxjnl-2021-217594
39.
BinghamPM, LahiriT and AshikagaT. Pilot trial of spirometer games for airway clearance practice in cystic fibrosis. Respir Care2012; 57: 1278–1284; doi: 10.4187/respcare.01263
40.
StarkLJ, Opipari-ArriganL, FilignoSS, et al.Web-based intervention for nutritional management in cystic fibrosis: development, usability, and pilot trial. J Pediatr Psychol2016; 41: 510–521; doi: 10.1093/jpepsy/jsv108
41.
SunsoaH, BarrettJ, GlennonE, et al.A prospective mixed‐methods pilot study of a novel group structured education programme for adults with cystic fibrosis diabetes. Practical Diabetes2024; 41: 12–21; doi: 10.1002/pdi.2518
42.
LaytonAM, IrwinAM, MihalikEC, et al.Telerehabilitation using fitness application in patients with severe cystic fibrosis awaiting lung transplant: a pilot study. Int J Telemed Appl2021; 2021: 6641853; doi: 10.1155/2021/6641853
43.
MorrisonL, McCreaG and PalmerS. Online activity - A beaming good initiative! Delivering alternative exercise opportunities for people with cystic fibrosis. Physiother Theory Pract2024; 40: 1609–1615; doi: 10.1080/09593985.2023.2182654
44.
del CorralT, PercegonaJ, SeborgaM, et al.Physiological response during activity programs using Wii-based video games in patients with cystic fibrosis (CF). J Cyst Fibros2014; 13: 706–711; doi: 10.1016/j.jcf.2014.05.004
45.
O’DonovanC, GreallyP, CannyG, et al.Active video games as an exercise tool for children with cystic fibrosis. J Cyst Fibros2014; 13: 341–346; doi: 10.1016/j.jcf.2013.10.008
46.
SaloniniE, GambazzaS, MeneghelliI, et al.Active video game playing in children and adolescents with cystic fibrosis: exercise or just fun? Respir Care2015; 60: 1172–1179; doi: 10.4187/respcare.03576
47.
del CorralT, Cebrià I IranzoMÀ, López-de-Uralde-VillanuevaI, et al.Effectiveness of a home-based active video game programme in young cystic fibrosis patients. Respiration2018; 95: 87–97; doi: 10.1159/000481264
48.
HolmesCJ, RacetteSB, SymondsL, et al.Feasibility and efficacy of telehealth-based resistance exercise training in adolescents with cystic fibrosis and glucose intolerance. Int J Environ Res Public Health2022; 19: 3297; doi: 10.3390/ijerph19063297
49.
VendrusculoFM, da CostaGA, BagatiniMA, et al.Feasibility of performing the 3-minute step test with remote supervision in children and adolescents with cystic fibrosis: a comparative study. Pediatr Investig2024; 8: 83–90; doi: 10.1002/ped4.12436
50.
KilicK, Vardar-YagliN, Nayir-BuyuksahinH, et al.Exercise intolerance, oxidative stress, and irisin in pediatric cystic fibrosis: can telehealth-based exercise training make a difference? Heart Lung2024; 68: 145–153; doi: 10.1016/j.hrtlng.2024.06.016
51.
CarrSB, RonanP, LorencA, et al.Children and Adults Tai Chi Study (CF-CATS2): a randomised controlled feasibility study comparing internet-delivered with face-to-face Tai Chi lessons in cystic fibrosis. ERJ Open Res2018; 4: e00042-18–e02018; doi: 10.1183/23120541.00042-2018
52.
ChenJJ, CooperDM, HaddadF, et al.Tele-exercise as a promising tool to promote exercise in children with cystic fibrosis. Front Public Health2018; 6: 269; doi: 10.3389/fpubh.2018.00269
53.
CamposNE, Heinzmann-FilhoJP, BeckerNA, et al.Evaluation of the exercise intensity generated by active video gaming in patients with cystic fibrosis and healthy individuals. J Cyst Fibros2020; 19: 434–441; doi: 10.1016/j.jcf.2020.01.001
54.
HillenB, SimonP, SchlotterS, et al.Feasibility and implementation of a personalized, web-based exercise intervention for people with cystic fibrosis for 1 year. BMC Sports Sci Med Rehabil2021; 13: 95; doi: 10.1186/s13102-021-00323-y
55.
CoxNS, EldridgeB, RawlingsS, Youth Activity Unlimited – A Strategic Research Centre of the UK Cystic Fibrosis Trust. Web-based physical activity promotion in young people with CF: a randomised controlled trial. et al.Thorax2023; 78: 16–23; doi: 10.1136/thorax-2022-218702
56.
WilkinsonOM, Duncan-SkingleF, PryorJA, et al.A feasibility study of home telemedicine for patients with cystic fibrosis awaiting transplantation. J Telemed Telecare2008; 14: 182–185; doi: 10.1258/jtt.2008.070107
57.
FidikaA, HerleM, LehmannC, et al.A web-based psychological support program for caregivers of children with cystic fibrosis: a pilot study. Health Qual Life Outcomes2015; 13: 11; doi: 10.1186/s12955-015-0211-y
58.
O’HayerCV, O’LoughlinCM, NurseCN, et al.ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis. J Cyst Fibros2021; 20: 133–139; doi: 10.1016/j.jcf.2020.11.013
59.
BathgateCJ, KilbournKM, MurphyNH, et al.Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis. J Cyst Fibros2022; 21: 332–338; doi: 10.1016/j.jcf.2021.07.012
60.
O’HayerCV, SmithPJ, DrescherCF, et al.ACT with CF: a randomized trial of acceptance and commitment therapy vs supportive psychotherapy for adults with cystic fibrosis. Gen Hosp Psychiatry2024; 91: 212–222; doi: 10.1016/j.genhosppsych.2024.11.011
61.
GrazianoS, BoldriniF, RighelliD, et al.Psychological interventions during COVID pandemic: telehealth for individuals with cystic fibrosis and caregivers. Pediatr Pulmonol2021; 56: 1976–1984; doi: 10.1002/ppul.25413
62.
ShakkottaiA, KacirotiN, KasmikhaL, et al.Impact of home spirometry on medication adherence among adolescents with cystic fibrosis. Pediatr Pulmonol2018; 53: 431–436; doi: 10.1002/ppul.23950
63.
YeungAWK, TorkamaniA, ButteAJ, et al.The promise of digital healthcare technologies. Front Public Health2023; 11: 1196596; doi: 10.3389/fpubh.2023.1196596
64.
MumtazH, RiazMH, WajidH, et al.Current challenges and potential solutions to the use of digital health technologies in evidence generation: a narrative review. Front Digit Health2023; 5: 1203945; doi: 10.3389/fdgth.2023.1203945
65.
Statista. Projected global digital health market size from 2019 to 2025. Statista, 2025.
66.
Statista. Digital health – worldwide. Statista, 2025.
67.
GoetzDM, BrownRF, FilignoSS, CFF Care Model Committee. et al.Cystic fibrosis foundation position paper: redefining the CF care model. J Cyst Fibros2024; 23: 1055–1065; doi: 10.1016/j.jcf.2024.08.007
68.
HofmannSG, AsnaaniA, VonkIJJ, et al.The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res2012; 36: 427–440; doi: 10.1007/s10608-012-9476-1
69.
ÖstL-G. The efficacy of acceptance and commitment therapy: an updated systematic review and meta-analysis. Behav Res Ther2014; 61: 105–121; doi: 10.1016/j.brat.2014.07.018
70.
KaryotakiE, EfthimiouO, MiguelC, Individual Patient Data Meta-Analyses for Depression (IPDMA-DE) Collaboration. et al.Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry2021; 78: 361–371; doi: 10.1001/jamapsychiatry.2020.4364[Erratum in JAMA Psychiatry. 2024 Mar 1;81(3):320; doi: 10.1001/jamapsychiatry.2023.5122]
71.
CarlbringP, AnderssonG, CuijpersP, et al.Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther2018; 47: 1–18; doi: 10.1080/16506073.2017.1401115
72.
VigerlandS, LenhardF, BonnertM, et al.Internet-delivered cognitive behavior therapy for children and adolescents: a systematic review and meta-analysis. Clin Psychol Rev2016; 50: 1–10; doi: 10.1016/j.cpr.2016.09.005
73.
Babiano-EspinosaL, WoltersLH, WeidleB, et al.Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review. Syst Rev2019; 8: 284; doi: 10.1186/s13643-019-1166-6
74.
WangS, GaoL, WangC, et al.Effects of internet based cognitive behavioral therapy on anxiety and depressive symptoms among patients with cardiovascular and cerebrovascular diseases: a systematic review and meta-analysis. Front Psychiatry2024; 15: 1433558; doi: 10.3389/fpsyt.2024.1433558
75.
KällA, BiliunaiteI and AnderssonG. Internet-delivered cognitive behaviour therapy for affective disorders, anxiety disorders and somatic conditions: an updated systematic umbrella review. Digit Health2024; 10: 20552076241287643–20552076241287620; doi: 10.1177/20552076241287643
76.
KelsonJ, RollinA, RidoutB, et al.Internet-delivered acceptance and commitment therapy for anxiety treatment: systematic review. J Med Internet Res2019; 21: e12530; doi: 10.2196/12530
77.
ThabrewH, StasiakK, HetrickSE, et al.E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions. Cochrane Database Syst Rev2018; 8: CD012489; doi: 10.1002/14651858.CD012489.pub2
78.
TorousJ, LinardonJ, GoldbergSB, et al.The evolving field of digital mental health: current evidence and implementation issues for smartphone apps, generative artificial intelligence, and virtual reality. World Psychiatry2025; 24: 156–174; doi: 10.1002/wps.21299
79.
HigginsKS, TutelmanPR, ChambersCT, et al.Availability of researcher-led eHealth tools for pain assessment and management: barriers, facilitators, costs, and design. Pain Rep2018; 3: e686; doi: 10.1097/PR9.0000000000000686
80.
JohnsonH. About 2.5 billion people lack internet access: how technology can unlock their potential. World Economic Forum, 2024,
81.
ButcherCJT and HussainW. Digital healthcare: the future. Future Healthc J2022; 9: 113–117; doi: 10.7861/fhj.2022-0046
82.
HartlingL, ChisholmA, ThomsonD, et al.A descriptive analysis of overviews of reviews published between 2000 and 2011. PLoS One2012; 7: e49667; doi: 10.1371/journal.pone.0049667
83.
HigginsJP, RamsayC, ReevesBC, et al.Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods2013; 4: 12–25; doi: 10.1002/jrsm.1056[Erratum in Res Synth Methods. 2013 Sep;4(3):287-9. doi: 10.1002/jrsm.1089]
84.
BabicA, PijukA, BrázdilováL, et al.The judgement of biases included in the category “other bias” in Cochrane systematic reviews of interventions: a systematic survey. BMC Med Res Methodol2019; 19: 77; doi: 10.1186/s12874-019-0718-8
85.
BabicA, TokalicR, Amílcar Silva CunhaJ, et al.Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability. BMC Med Res Methodol2019; 19: 76; doi: 10.1186/s12874-019-0717-9
86.
GatesM, GatesA, DuarteG, et al.Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers. J Clin Epidemiol2020; 125: 9–15; doi: 10.1016/j.jclinepi.2020.04.026
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
